MergerLinks Header Logo

Submit Deal

Submit Deal

Announced

Celltrion USA to acquire Imclone Systems from Eli Lilly and Company for $330m.

Synopsis

Celltrion USA, a subsidiary of the global biopharmaceutical company Celltrion Korea, agreed to acquire Imclone Systems, a biopharmaceutical company, from Eli Lilly and Company, a company that discovers, develops, manufactures, and sells pharmaceutical products for humans and animals, for $330m.

Principals

Imclone Systems

target

Imclone Systems

Celltrion Usa

bidder

Celltrion Usa

Show Details & Financials

Did you work on this deal?

Claim Deal

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Claim Deal

Market Context

Privacy PolicyTerms of ServiceContact UsCookie Preferences

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Celltrion USA to acquire Imclone Systems from Eli Lilly and Company for $330m.